dapagliflozin 10 MG / saxagliptin 5 MG Oral Tablet [Qtern]

RxCUI
1925504
RxNorm name
dapagliflozin 10 MG / saxagliptin 5 MG Oral Tablet [Qtern]
Display name
QTERN (Oral Pill)
Full name
dapagliflozin 10 MG / saxagliptin 5 MG Oral Tablet [Qtern]
Term type
SBD
Status
Active
Strength
10-5 mg
Dose form
Tab
Route
Oral Pill
Updated
2026-10-29 07:12:20

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
072017
Active start
072017
Multiple ingredient
YES
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
dapagliflozin propanediol10 MG / 1 EACHdapagliflozindapagliflozin
saxagliptin hydrochloride5 MG / 1 EACHsaxagliptinsaxagliptin

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Tablet317541

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
dapagliflozin1488564
saxagliptin857974

Source Vocabulary Codes#

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 2 matching rows.

NDC11, Source, Active table
NDC11SourceActive
00310678030rxnav_ndcsyes
00310678095rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
423c489c-085b-4320-b892-7868ebd6dc6bThese highlights do not include all the information needed to use QTERN safely and effectively. See full prescribing information for QTERN . QTERN® (dapagliflozin and saxagliptin) tablets, for oral use Initial U.S. Approval: 2017AstraZeneca Pharmaceuticals LP | AstraZeneca PLC20241113

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCA10BDCombinations of oral blood glucose lowering drugsATC1-4dapagliflozin / saxagliptin
ATCA10BHDipeptidyl peptidase 4 (DPP-4) inhibitorsATC1-4saxagliptin
ATCA10BKSodium-glucose co-transporter 2 (SGLT2) inhibitorsATC1-4dapagliflozin
FDASPLN0000187059Sodium-Glucose Cotransporter 2 InhibitorEPChas_epcdapagliflozin
FDASPLN0000187058Sodium-Glucose Transporter 2 InhibitorsMOAhas_moadapagliflozin
MEDRTD000218AdamantaneCHEMhas_ingredientsaxagliptin
MEDRTD001559Benzhydryl CompoundsCHEMhas_ingredientdapagliflozin
MEDRTD004151DipeptidesCHEMhas_ingredientsaxagliptin
MEDRTD005960GlucosidesCHEMhas_ingredientdapagliflozin
MEDRTD003924Diabetes Mellitus, Type 2DISEASEmay_treatdapagliflozin
MEDRTD003924Diabetes Mellitus, Type 2DISEASEmay_treatsaxagliptin
MEDRTD004342Drug HypersensitivityDISEASEci_withsaxagliptin
MEDRTD006333Heart FailureDISEASEmay_treatdapagliflozin
MEDRTN0000175912Dipeptidyl Peptidase 4 InhibitorsMOAhas_moasaxagliptin
MEDRTN0000187058Sodium-Glucose Transporter 2 InhibitorsMOAhas_moadapagliflozin
MEDRTN0000008644Decreased Glucagon SecretionPEhas_pesaxagliptin
MEDRTN0000175650Decreased Sympathetic ActivityPEhas_pedapagliflozin
MEDRTN0000009360Increased Insulin SecretionPEhas_pesaxagliptin
MEDRTN0000009556Increased Renal Organic Ion ExcretionPEhas_pedapagliflozin
MEDRTN0000009830Renal Ion Transport AlterationPEhas_pedapagliflozin

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH10 MG / 5 MG
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
NAMESPrescribable SynonymQTERN 10 MG / 5 MG Oral Tablet
NAMESTallman Synonymdapagliflozin 10 MG / sAXagliptin 5 MG Oral Tablet [Qtern]
NAMESTallman SynonymQtern (dapagliflozin 10 MG (as dapagliflozin propanediol 12.3 MG) / sAXagliptin 5 MG (as sAXagliptin HCl 5.95 MG)) Oral Tablet
NAMESTallman SynonymQtern (dapagliflozin 10 MG / sAXagliptin 5 MG) Oral Tablet
SOURCESSourceMultum MediSource Lexicon